Last update : 04/12/2012 | Version : 1 | ID : 218
General | |
Identification | |
Detailed name | Côte d'Or registry of hematological malignancies |
Sign or acronym | RHEMCO |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL 97.013 |
General Aspects | |
Medical area |
Cancer research |
Others (details) | hematological malignancies |
Keywords | public health, surveillance, evaluation |
Scientific investigator(s) (Contact) | |
Name of the director | Maynadié |
Surname | Marc |
Address | Faculté de Médecine – 7 Boulevard Jeanne d’Arc – 21078 Dijon cedex |
Phone | + 33 (0)3 80 39 34 16 |
marc.maynadie@chu-dijon.fr | |
Organization | CHU |
Collaborations | |
Funding | |
Funding status |
Public |
Details | Institut national de veille sanitaire - InVS Institut national du cancer - INCa |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | CHU Dijon |
Organisation status |
Public |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Morbidity registers |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. |
Selection of subjects having the required inclusion criteria. Several sources are used to identify cases: - Medical Biology Laboratories - Specialist laboratories (Hematology, Cytogenetics) - Pathological Anatomy Structures - Death certificates - PMSI (hospital diagnosis-related group database) - Cancer registry of the Doubs département - Clinical departments - Attending physician - RNIPP |
Database objective | |
Main objective |
Objectives of the registry in terms of public health (surveillance, evaluation): 1) listing of all cases of hematological malignancies occurring in a well-defined population so as to provide the health and social authorities with precise data regarding the incidence, breakdown per gender, age range, geographical zone and socioprofessional category of these diseases; 2) recording of data on these cases makes it possible to evaluate different characteristics such as the stage of diagnosis, elements of the diagnosis and cancer staging report, therapy and survival; 3) a role to alert the public authorities in the rapid rise in incidence of certain pathologies and in the identification of the cause of this rise; 4) a role in improving the quality of data on hematological malignancies in the general cancer registries. - Objectives of the registry in terms of research; 1) in etiological epidemiology with the detection of environmental, personal and family risk factors of hematological malignancies; 2) in molecular epidemiology with the development of genetic or epigenetic research, 3) in pharmacological epidemiology with the development of therapies, their setting up, access to new therapies and their effect at population level on patient survival, the quality of this survival and the distant consequences of their use; 4) setup of tumor tissue collection |
Inclusion criteria |
The cases recorded are malignant proliferations developed from cell types constituting the hematopoietic tissue diagnosed, in subjects living in the Côte d'Or département for more than 6 months |
Population type | |
Age |
Newborns (birth to 28 days) Infant (28 days to 2 years) Early childhood (2 to 5 years) Childhood (6 to 13 years) Adolescence (13 to 18 years) Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
Departmental |
French regions covered by the database |
Bourgogne Franche-Comté |
Detail of the geography area | Côte d'or |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 1980 |
Date of last collection (YYYY or MM/YYYY) | 2009 |
Size of the database | |
Size of the database (number of individuals) |
[1000-10 000[ individuals |
Details of the number of individuals | 1980-2004: 5087 |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Biological data Administrative data |
Clinical data (detail) |
Direct physical measures |
Biological data (detail) | Diagnostic and prognostic data: cytology, immunophenotyping, cytogenetics, molecular biology, pathological anatomy, biochemical markers |
Administrative data (detail) | place of birth, residence, marital status, profession |
Presence of a biobank |
Yes |
Contents of biobank |
Serum Blood cells isolated DNA DNAc/RNAm |
Details of biobank content | Biological samples are stored in the Ferdinand Cabanne Biological Resource Center (www.crbferdinandcabanne.fr/) |
Health parameters studied |
Health event/morbidity Health event/mortality Health care consumption and services Quality of life/health perception |
Care consumption (detail) |
Medicines consumption |
Procedures | |
Data collection method | Active or passive |
Participant monitoring |
Yes |
Details on monitoring of participants | - Vital status - Sample-based follow-up is conducted depending on the objectives defined. |
Links to administrative sources |
Yes |
Linked administrative sources (detail) | - RNIPP - PMSI |
Promotion and access | |
Promotion | |
Link to the document | http://www.ncbi.nlm.nih.gov/pubmed?term |
Link to the document | http://epi.grants.cancer.gov/InterLymph/ |
Link to the document | http://www.Haemacare.eu |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) |
publications, InVS (French Institute for Public Health Surveillance) website, annual reports to the InVS. Regarding access to the registry's data, interested researchers may contact the scientific manager who will assess their requests. |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05